Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Fumiaki Miyamae"'
Autor:
Yoshikazu Ogawa, Fumiaki Miyamae, Masahiro Egawa, Akira Yamasaki, Katsuyuki Tomita, Kuniko Yatsumoto, Toshiaki Yamaashi, Kazuki Fukuda
Publikováno v:
International journal of clinical pharmacology and therapeutics. 57(7)
OBJECTIVE In elderly patients, age-related, disease-related, and drug-related factors are associated with chronic kidney disease (CKD). Little is known about which factors are the best predictors for CKD in elderly patients. MATERIALS AND METHODS The
Autor:
Fumiaki Miyamae, Tetsuto Tsunoda, Mitsuyo Horikawa, Makoto Yoshizuka, Makoto Inai, Takeshi Nishii, Hiroto Kaku
Publikováno v:
Tetrahedron: Asymmetry. 23:739-741
Excess lithium hexamethyldisilazide (LHMDS) with LiCl prompted the asymmetric aza-Claisen rearrangement of carboxamide and retarded the decomposition of its amide enolate. The addition of these two reagents was a key step that led to the total synthe
Autor:
Takayoshi Kiba, Takuo Ito, Toshihisa Nakashima, Yoshiko Okikawa, Miki Kido, Akiko Kimura, Keita Kameda, Fumiaki Miyamae, Suzuko Tanaka, Misao Atsumi, Yoko Sumitani, Yoshimi Shitakubo, Hiromasa Niimi
Publikováno v:
BMC Cancer; 2014, Vol. 14 Issue 1, p160-177, 18p
Autor:
Misao Atsumi, Fumiaki Miyamae, Akiko Kimura, Takayoshi Kiba, Suzuko Tanaka, Toshihisa Nakashima, Keita Kameda, Takuo Ito, Yoshimi Shitakubo, Miki Kido, Yoshiko Okikawa, Hiromasa Niimi, Yoko Sumitani
Publikováno v:
BMC Cancer
Background Bortezomib offers a novel approach to the treatment of multiple myeloma producing rapid control. The aim of this study was to investigate the outcomes of bortezomib and dexamethasone-treated patients with multiple myeloma. Methods We condu